Provider review A board-certified medical provider will review your information and create your personalized plan
Low insulin-like growth factor-1 could also indicate problems in the liver or kidneys as these organs are most responsible for producing it
In other words, GLP-1 and GLP-1RAs modulate the molecular and cellular changes that determine the phenomenology of NDD and other brain diseases [36]
As Ozempic and Wegovy have become more popular, not everyone has been able to access or afford these branded medications
We now know that patients frequently discontinue GLP-1 therapy within months, negating long-term benefits, and also struggle to meet the requirements of lifestyle changes that are prescribed alongside the medication
These new treatment possibilities for clinicians, coupled with an increase in industry marketing and patients personal needs, have led to an explosion of prescriptions for these drugs especially in Western countries [9]